M
ABBV icon

Mirova’s AbbVie ABBV Stock Holding History

Mirova’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
68,391
+40,342
+144% +$8.68M 0.64% 46
2026
Q1 		$6.1M Buy
+28,049
New +$6.22M 0.25% 107
2024
Q2 		– Sell
-1,249
Closed -$227K – 124
2024
Q1 		$227K Hold
1,249
– – 0.04% 104
2023
Q4 		$194K Sell
1,249
-76
-6% -$11.1K 0.04% 85
2023
Q3 		$198K Sell
1,325
-3,499
-73% -$514K 0.04% 88
2023
Q2 		$650K Sell
4,824
-5,963
-55% -$874K 0.11% 79
2023
Q1 		$1.72M Sell
10,787
-229
-2% -$35K 0.25% 68
2022
Q4 		$1.78M Buy
11,016
+1,155
+12% +$177K 0.28% 72
2022
Q3 		$1.32M Sell
9,861
-1,500
-13% -$215K 0.22% 76
2022
Q2 		$1.74M Buy
11,361
+753
+7% +$115K 0.25% 68
2022
Q1 		$1.72M Sell
10,608
-175
-2% -$25.4K 0.23% 60
2021
Q4 		$1.46M Buy
10,783
+4,831
+81% +$571K 0.17% 70
2021
Q3 		$642K Buy
5,952
+525
+10% +$60K 0.08% 106
2021
Q2 		$611K Hold
5,427
– – 0.07% 97
2021
Q1 		$587K Buy
5,427
+876
+19% +$93.7K 0.07% 94
2020
Q4 		$487K Buy
4,551
+3,219
+242% +$309K 0.06% 91
2020
Q3 		$117K Sell
1,332
-317
-19% -$29.8K 0.02% 88
2020
Q2 		$162K Sell
1,649
-6
-0.4% -$528 0.04% 66
2020
Q1 		$126K Sell
1,655
-788
-32% -$67.1K 0.05% 73
2019
Q4 		$216K Buy
2,443
+760
+45% +$63.1K 0.08% 77
2019
Q3 		$127K Buy
1,683
+152
+10% +$10.4K 0.02% 85
2019
Q2 		$111K Hold
1,531
– – 0.01% 87
2019
Q1 		$123K Buy
1,531
+456
+42% +$37.3K 0.07% 68
2018
Q4 		$99K Buy
+1,075
New +$94.5K 0.05% 69

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirova's ABBV Position: Q2 2026 in Review

Mirova increased its AbbVie (ABBV) stake by 144% in Q2 2026, buying an estimated $8.68M and bringing the position to 68,391 shares worth $17.2M. The position accounts for 0.64% of the portfolio, ranked #46.

Mirova first reported a position in ABBV in Q4 2018 and has held it in 24 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mirova held 68,391 shares of AbbVie worth $17.2M as of Q2 2026.
  • Mirova bought 40,342 AbbVie shares in Q2 2026, an estimated $8.68M.
  • AbbVie made up 0.64% of Mirova's portfolio in Q2 2026, its #46 holding.
  • Mirova first reported a position in AbbVie in Q4 2018 and has held it in 24 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.